Products

LEKWhite TRX (Tranexamic Acid)

    • Product Name: LEKWhite TRX (Tranexamic Acid)
    • Alias: lekwhite_trx
    • Einecs: 222-720-6
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    863427

    Product Name LEKWhite TRX
    Active Ingredient Tranexamic Acid
    Formulation Type Topical
    Intended Use Skin brightening
    Concentration 2%
    Key Benefit Reduces hyperpigmentation
    Skin Types All skin types
    Application Frequency Twice daily
    Texture Lightweight serum
    Country Of Origin Thailand

    As an accredited LEKWhite TRX (Tranexamic Acid) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing LEKWhite TRX (Tranexamic Acid) comes in a white, sealed 1kg plastic pouch with blue labeling and clear product details.
    Shipping LEKWhite TRX (Tranexamic Acid) is shipped in secure, sealed packaging to maintain product integrity. It is typically transported at controlled room temperature, with clear labeling for identification and safety. Compliance with relevant chemical transport regulations ensures safe delivery. Shipping documentation includes certificates of analysis and material safety data sheets (MSDS).
    Storage LEKWhite TRX (Tranexamic Acid) should be stored in a cool, dry place, away from direct sunlight and moisture, ideally at room temperature (below 30°C/86°F). Keep the container tightly closed and out of reach of children. Avoid exposure to heat or freezing conditions. Store in its original packaging to protect from light and maintain stability.
    Application of LEKWhite TRX (Tranexamic Acid)

    Applications of LEKWhite TRX (Tranexamic Acid) in Industrial Manufacturing

    LEKWhite TRX is a high-purity tranexamic acid manufactured in-house for advanced applications in medical, cosmetic, and pharmaceutical industries. Our direct integration from synthesis to packing ensures traceability and consistent lot quality, supporting regulatory compliance and sophisticated downstream formulation processes. Below, we outline key application areas where our material supports differentiated industrial usage.

    1. Pharmaceutical-Grade Hemostatic Formulations

    Tranexamic acid is essential in the production of hemostatic formulations for tablet and injectable preparations, where precise purity and consistency are demanded for safety and clinical effectiveness. Manufacturers engage in wet granulation or lyophilization processes, incorporating our material during blending or solution preparation steps for stability and verified content uniformity. Quality assurance teams validate each batch using pharmacopeial analytical benchmarks before release to the downstream production line.

    Industry compliance standards

    • USP, EP, JP Pharmacopoeia monographs for Tranexamic Acid
    • FDA cGMP for Finished Pharmaceuticals (21 CFR Part 210/211)
    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • WHO GMP for Pharmaceutical Products

    Typical usage ratio

    • 5–12% w/w in oral or parenteral blend; proportion varies with intended tablet, capsule, or solution strength; formulation chemists adjust depending on dosage design and excipient matrix.

    Downstream process integration

    • Introduced post-milling during active blend; in injectables, dissolved directly into isotonic aqueous phase prior to sterile filtration; for tablets, incorporated during wet granulation for homogeneous distribution.

    Final product types

    • Hemostatic tablets and capsules
    • Injectable ampoules and prefilled syringes
    • Oral suspension preparations

    2. Dermatological and Hyperpigmentation Cosmetic Actives

    Tranexamic acid is widely incorporated in skin care serum and cream manufacturing targeted at hyperpigmentation, melasma, and sensitive skin brightening. Cosmetic formulators require precise micro-dosing in aqueous or emulsion bases, controlling pH and preventing degradation. Our material’s high purity mitigates risk of allergenic impurities. Manufacturers validate integration at the aqueous phase and maintain ISO 22716 Good Manufacturing Practice for Cosmetics throughout batch preparation and packaging.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • China NMPA Cosmetic Safety and Technical Standards
    • ISO 22716: Cosmetics GMP
    • ASEAN Cosmetic Directive Annexes

    Typical usage ratio

    • 0.2–3% w/w in final formulation; formulators assess effective concentration against regulatory maximum and product type; typical facial serums use 2%.

    Downstream process integration

    • Added during aqueous phase mixing, prior to primary emulsion or gel formation; temperature monitored below 40°C to preserve molecular stability; continuous mixing ensures homogeneity before filling.

    Final product types

    • Brightening serums for melasma and dark spot reduction
    • Face creams addressing hyperpigmentation
    • Cosmeceutical ampoules for clinic and retail
    • Sheet mask concentrates

    3. Oral Care Whitening and Sensitive Formulas

    Manufacturers of specialized toothpaste and oral care gels use tranexamic acid for its established anti-inflammatory and anti-melanin effects. High-precision dosing is implemented using microweighing in blending tanks, with attention on preventing cross-contamination and ensuring accurate calibration of metering pumps. Our component’s ensured purity supports the demands of ISO 9001 batch traceability, HACCP hygiene control, and specific dental product standards across major export markets.

    Industry compliance standards

    • ISO 13485 for Dental Device Manufacturing
    • EN ISO 22716:2007 (Cosmetic GMP) for Oral Care
    • FDA OTC Monograph for Antigingivitis and Oral Wound Solutions
    • China GB/T 8372 Toothpaste Safety Standard

    Typical usage ratio

    • 0.1–1% w/w for toothpaste and gel formulations; formulators evaluate according to target performance, product type, and regulation on ingredient claims.

    Downstream process integration

    • Incorporated during hydration phase with humectants and binders; blending continues until uniform suspension is achieved prior to flavor addition and tube filling; QC validation ensures even dispersion.

    Final product types

    • Toothpastes targeting gum sensitivity and oral discoloration
    • Whitening mouth gels for at-home and professional use
    • Anti-gingivitis oral rinses

    4. Advanced Wound Care and Hemostatic Dressings

    Tranexamic acid serves as an active ingredient in non-implantable wound care products such as hemostatic pads and biomedical sponges. It is loaded onto substrates during downstream fabrication and sterilized under validated conditions. Material traceability, low endotoxin verification, and batch certification are mandatory under MDR and FDA QSR quality frameworks. Engineers monitor application uniformity and stability under accelerated and real-time storage assessments to ensure effective clinical use.

    Industry compliance standards

    • EU Medical Device Regulation (MDR) 2017/745
    • FDA 21 CFR 820 Quality System Regulation
    • ISO 10993 Biocompatibility Evaluation for Medical Devices
    • ISO 13995:2011 for Surgical Drape and Gown Barrier Systems

    Typical usage ratio

    • 1–6% w/w on wound dressing; exact ratio tailored by R&D teams for absorption, substrate thickness, and clinical indication.

    Downstream process integration

    • Dissolved in aqueous solution and applied to spunlace or polyurethane foams using spray, dropwise, or immersion techniques before drying and cutting; sterilized by gamma or ethylene oxide as required.

    Final product types

    • Hemostatic wound pads
    • Absorbent surgical dressings
    • Imbued hemostatic sponges for trauma kits

    5. Injectable Lyophilized APIs for Hospital Supply

    Large-volume sterile manufacturing relies on our material for consistent, pyrogen-free input in unit dose lyophilized vials. Production managers synchronize lot release with stringent environmental controls (Class 100 cleanroom), solution compounding, sterile filtration, and fill-finish stages. Each API batch is tested to meet leading hospital supply network and tender requirements with full documentation for international regulatory submission.

    Industry compliance standards

    • USP/EP/JP Pharmacopoeia for Parenteral APIs
    • EU GMP Annex 1 for Sterile Manufacturing
    • FDA 21 CFR 211 for Finished Pharmaceuticals
    • WHO Prequalification Program

    Typical usage ratio

    • 100 mg–1 g per vial, reconstitution standard; exact fill mass depends on therapeutic protocol and market requirement.

    Downstream process integration

    • Chemically dissolved in Water for Injection (WFI), sterile filtered under laminar flow, aliquoted into vials, then lyophilized and sealed under validated process controls; packaged with tamper-evidence for hospital pharmacy delivery.

    Final product types

    • Lyophilized API vials for intravenous reconstitution
    • Hospital-use tranexamic acid injection kits
    • Bulk API lots for reference pharmaceutical manufacturers

    Free Quote

    Competitive LEKWhite TRX (Tranexamic Acid) prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    LEKWhite TRX (Tranexamic Acid): Reliable Ingredient Forged from Experience

    Groundwork in Chemical Manufacturing

    Every product that leaves our reactors bears the weight of decades spent on production floors, in quality control labs, in heated discussions about crystalline forms and particle size. When it comes to LEKWhite TRX, there is more than chemistry in the bag; there is a commitment built from thousands of metric tons produced, batches checked, and partners served. Tranexamic acid has found its way into a wide array of industries—pharmaceuticals, personal care, and specialty formulations. Through these journeys, LEKWhite TRX has evolved. Our experience tells us purity isn’t just a number; it forms the backbone of product safety and yield.

    What Sets LEKWhite TRX Apart

    Anyone can ship a drum labeled “tranexamic acid,” but not every offering is free of legacy issues: metallic impurities slipping past, off-white tints hinting at failed oxidation prevention, particle size distributions wavering batch to batch. LEKWhite TRX began as a challenge to these shortcomings. Every lot runs through consistency checks for color, solubility, moisture, and even odor—a detail tracking back to upstream purification stages. Raw materials arrive only from sources that regularly audit themselves for trace contamination, because contaminants can derail entire runs downstream for both injectables and tablets.

    We've standardized our production on a crystalline grade with a purity exceeding 99%. This sets up customers with a baseline reliability that helps reduce unexpected reactions and improve yield in formulation. You’ll never see unexpected polydispersity cropping up mid-delivery; a fixed particle size sits at the intersection of years guiding filtration and drying systems, rather than chasing the numbers in a spec sheet.

    Environmental protection has forced every chemical maker to change. Our operations moved from solvent-heavy extraction to processes capped at strict discharge standards. Waste minimization, heat recovery, and an on-site closed-loop water system keep downstream products like LEKWhite TRX from feeding into environmental headaches elsewhere. Years ago, dust mitigation barely got a mention. Now, every transfer step receives regular monitoring, and workers calibrate handling routines quarterly.

    Why Specification Tables Don’t Tell the Whole Story

    Practitioners trust numbers, but experience shapes which numbers matter. The LC-MS curves on our finished LEKWhite TRX are kept clean—side products or residual solvents show up rarely, which matters for compounding into sensitive topical gels, oral tablets, or parenteral solutions. Some buyers still ask about arsenic, heavy metals, and microbiological content; these values sit well below global pharmacopeial limits, supported by routine third-party tests. Software counts by the microgram, but only a well-run process delivers year after year.

    The color—often overlooked—signals deeper clues. Off-white batches almost always point to a slip upstream, often connected to solvent systems or aging raw stock. We tackled this by reworking our oxidation protocols, tweaking cooling rates, and training operators to recognize visual cues before final blending. Downstream customers found the difference: no degradation of color in creams, no odd odors leaching out two months later.

    Resolving the Real-World Hurdles

    Some customers struggle with caking and solubility issues when they trial poor-quality material, especially at higher concentrations. We switched to a refining design centered around gentle drying cycles and anti-caking drum linings, learning from repeated failures. Finished LEKWhite TRX disperses quickly, reducing agitation times—a small gain for lab techs, but a huge cost saver for anyone stirring vats.

    Across the personal care sector, we started fielding questions about photo-stability and cross-reactivity. Trials with sun-care customers revealed that trace byproducts—undetectable in routine HPLC—could yellow certain gels. Our response included extra purification cycles and a new packaging partnership using UV-block opaque bags. Returns dropped, confidence rose.

    Shipping reliability doesn’t just count on certificates of analysis. We made direct investments in climate-controlled warehousing and dedicated temperature loggers for every outbound shipment. No more excusing product changes from temperature swings between storage and end-use. Every year, we run dry-run simulated audits from warehouse to bulk tanker to catch possible slips in stability, learning from the rare outlier.

    Tranexamic Acid Uses and Downstream Demands

    Tranexamic acid gained most of its fame for controlling systemic bleeding, then for skin-lightening in personal care, and now for specialty applications where purity impacts product performance and liability risks. Each end-user sector carries its own sensitivities. Our pharma partners demand batch traceability. Cosmetic brands chase a clean reputation—minimal residual solvents, zero contamination by banned substances, and the right hue for easy blending into finished products.

    A significant focus has landed on the microbiological integrity of each lot, especially for customers pushing for preservative-free systems. We built validated clean rooms for final packaging, with regular monitoring of airborne particulates and bioburden. Years of near-misses revealed weak points—inlet air systems, glovebox handling, gowning protocols. Every lesson shaped our revisions, ensuring clean batches actually stay clean until they arrive in the customer’s hands.

    As Asian, European, and US customers set ever-tighter import standards, we kept pace: regular updates to our DMF filings, on-call audits for FDA, and rapid responses when partners request special documentation. Experience showed us which paperwork earns customs clearance and which details cause month-long holdups.

    The Human Face of Quality Control

    All automation can produce data, but people spot trouble first. Crystallization operators run quick solubility checks, not because a computer told them to, but because the experience of a stubborn powder fouling a mixer still stings. One supervisor realized that start-up batches in winter ran slower, leading to higher-than-average moisture in the output. Adjustments to drying schedules fixed countless small problems that no sensor would have noticed.

    Down the supply chain, formulating partners return feedback—some formal, some hurried comments over calls—about flowability or compatibility with buffers. Our team doesn’t dismiss this input as background noise. Instead, we run off-cycle experiments, shipping unrequested samples with tweaks based on customer suggestions. Sometimes the fixes cope with old impurities, sometimes they prevent new ones.

    The goal: a tranexamic acid that doesn’t interrupt your process, slow down production, or introduce new risks. LEKWhite TRX became that product only through years of open-loop feedback—thousands of small changes none of which show up in standard documents, but each one keeping our partners ahead of their own production hurdles.

    Model, Grade, and Packaging Choices Born from Iteration

    LEKWhite TRX’s crystalline form originated from countless trials adapting cooling curves and seeding procedures to coax out the right habit. Not all crystals act alike in formulation; differences in surface area, porosity, and size influence how quickly they dissolve and disperse. Bigger crystals reduce dust, smaller ones blend more evenly. We turned to end users—the people behind rotary tablet presses, emulsification kettles, granulators—to inform the final particle range. This eliminated upstream surprises like choking hoppers or slow dissolution in viscous base.

    For models, customers favored transparent labeling. We settled on two available grades of LEKWhite TRX, both tightly linked with pharmaceutical and personal care requirements, differentiated mainly by the granularity and target residual solvent levels. Our team validates each for compliance with the phthalate, plasticizer, and latex-free environments increasingly common in modern production lines.

    Packaging is the last gatekeeper. Every drum uses HDPE liners—free of phthalates and tested to withstand long-distance freight. The outside bears clear, tamper-evident seals, not just for peace of mind but to meet regulatory import checks in key markets. The switch to smaller, modular packaging resulted directly from repeated requests by pharma customers seeking just-in-time inventory flows. Each format fits right-sized to their process, minimizing waste during transfer and reducing exposure risks.

    Side-by-Side with the Competition

    Once, the shelves were full of products that only promised “tranexamic acid meeting pharmacopeia.” Lots of manufacturers deliver on paper, but there is a gap in real-world performance. LEKWhite TRX doesn’t blend the old approach of racing for the lowest specs. Our development drew from repeat failures in generic grades: unusual odors that only showed up after mixing, extra fines that settled out in storage, unpredictable yields from supplier-to-supplier.

    Competitors often overlook the direct impact of process drift—a subtle adjustment in crystallization one year, a shortcut in solvent recovery the next. We have a standing policy of batch-level review to spot early warning signs and bring corrective action before batches go out. This single point of focus prevents the slow creep of out-of-spec product that plagues bulk suppliers. Customer recalls grind work to a halt; our goal stands plain: preventing the recall before it becomes a topic.

    Some brands highlight mirror-polished packaging and marketing tags; real assets come from under the lid. Our regular outside proficiency tests show our heavy metal, nitrosamine, and residual solvent results at levels indistinguishable from high-purity APIs, despite selling at an industrial-grade price to non-pharma sectors. These facts didn’t happen by accident—they trace to regular investment in purification and monitoring equipment, upgraded at a rate set by partner needs.

    The comment that often returns from formulation teams: “This batch functions the same as your last, and the last a year before.” This predictability doesn’t originate in chance, but in endless cycle improvement—from operator to customer and back again.

    Every Batch Tells a Story

    At our site, everyone can trace the journey of a kilo of LEKWhite TRX—raw material receipt, processing, QC, and loading dock—through digital ledger and handwritten notes. Gaps, if found, become highlighted, discussed, and fixed, feeding better results into the next run. Plant managers keep open lines to the labs. Supply planners work alongside logistics. It isn’t about building a lean-sounding chain of custody; it’s about never losing sight of the people and choices behind each product.

    Everyone in the operation experiences the same pressure: the pulse of customer demand fluctuates with seasons, regulations, and launches. We’ve seen uses we never predicted—in dental whitening, in compounded injectables, in advanced material science. Every new application teaches another dimension to what tranexamic acid needs to offer. Only practical, reliable communication with end-users allows us to recognize blind spots and adapt before they become problems.

    We keep a vault of lessons: the year a power outage ruined a fermentation run; the month a cross-contaminated shipment threatened our compliance rating; the week a single poorly labeled drum caused a bottleneck across an entire continent. Each setback shaped a clearer rule set, where documentation, real-time data capture, and hands-on accountability mean we can fix errors before they multiply.

    Moving Forward with Confidence

    The landscape for tranexamic acid will keep shifting, with regulatory bodies updating requirements and new users exploring fringe applications. LEKWhite TRX faces strict evaluation in every batch—now and for every market it enters. We invest in new testing technology before legislation mandates adoption, often driven by lessons reported from the field.

    We run cross-functional training sessions so everyone understands not just the technical “what” but the practical “why.” If a team member found a way to reduce batch contamination risk, everyone hears about it. If a customer notices better dispersion at a certain pH, formulation chemists get the update. This cycle grows the product’s value beyond a list of specs—it roots LEKWhite TRX in lived experience across hundreds of partners, products, and challenges.

    LEKWhite TRX: Beyond the Label

    The tranexamic acid used globally today wasn’t born from one process or one innovation. It reflects dozens—sometimes hundreds—of technical interventions, regulatory demands, and customer-driven improvements. LEKWhite TRX became distinctive on the manufacturing line: the drive to perfect purity where phthalate scare stories make headlines, the determination to stay transparent with traceability and documentation, the willingness to solve new formulation puzzles before downstream users face them alone.

    Anyone seeking certainty in raw materials needs partners with clear-eyed commitment. In a landscape crowded with generic claims, every batch of LEKWhite TRX tells a story of experience, adaptation, and trust—values born far from the boardroom, proven daily on the plant floor and in customer labs around the world.

    Top